These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30318563)

  • 1. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized
    Del Prete M; Arsenault F; Saighi N; Zhao W; Buteau FA; Celler A; Beauregard JM
    EJNMMI Phys; 2018 Oct; 5(1):25. PubMed ID: 30318563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized
    Del Prete M; Buteau FA; Beauregard JM
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1490-1500. PubMed ID: 28361189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized
    Del Prete M; Buteau FA; Arsenault F; Saighi N; Bouchard LO; Beaulieu A; Beauregard JM
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):728-742. PubMed ID: 30506283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dead time on quantitative
    Desy A; Bouvet GF; Frezza A; Després P; Beauregard JM
    EJNMMI Phys; 2020 May; 7(1):32. PubMed ID: 32415492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
    Peterson AB; Mirando DM; Dewaraja YK
    EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.
    Peterson AB; Mirando DM; Dewaraja YK
    Res Sq; 2023 Apr; ():. PubMed ID: 37131738
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA
    Gosewisch A; Delker A; Tattenberg S; Ilhan H; Todica A; Brosch J; Vomacka L; Brunegraf A; Gildehaus FJ; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2018 Aug; 8(1):76. PubMed ID: 30076556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT).
    Chicheportiche A; Artoul F; Schwartz A; Grozinsky-Glasberg S; Meirovitz A; Gross DJ; Godefroy J
    EJNMMI Phys; 2018 Jun; 5(1):10. PubMed ID: 29916115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and accuracy of single time point imaging for renal dosimetry following
    Willowson KP; Eslick E; Ryu H; Poon A; Bernard EJ; Bailey DL
    EJNMMI Phys; 2018 Dec; 5(1):33. PubMed ID: 30569328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized radiation dosimetry for PRRT-how many scans are really required?
    Freedman N; Sandström M; Kuten J; Shtraus N; Ospovat I; Schlocker A; Even-Sapir E
    EJNMMI Phys; 2020 May; 7(1):26. PubMed ID: 32394075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized kidney dosimetry in
    Hou X; Zhao W; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175004. PubMed ID: 31456584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management.
    Chicheportiche A; Ben-Haim S; Grozinsky-Glasberg S; Oleinikov K; Meirovitz A; Gross DJ; Godefroy J
    EJNMMI Phys; 2020 Jan; 7(1):5. PubMed ID: 31975156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage PRRT with
    Rudisile S; Gosewisch A; Wenter V; Unterrainer M; Böning G; Gildehaus FJ; Fendler WP; Auernhammer CJ; Spitzweg C; Bartenstein P; Todica A; Ilhan H
    BMC Cancer; 2019 Aug; 19(1):788. PubMed ID: 31395036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive power of the post-treatment scans after the initial or first two courses of [
    Chicheportiche A; Grozinsky-Glasberg S; Gross DJ; Krausz Y; Salmon A; Meirovitz A; Freedman N; Godefroy J
    EJNMMI Phys; 2018 Dec; 5(1):36. PubMed ID: 30535780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective observational study of
    Garske-Román U; Sandström M; Fröss Baron K; Lundin L; Hellman P; Welin S; Johansson S; Khan T; Lundqvist H; Eriksson B; Sundin A; Granberg D
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):970-988. PubMed ID: 29497803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 177Lu-DOTATATE Theranostics: Predicting Renal Dosimetry From Pretherapy 68Ga-DOTATATE PET and Clinical Biomarkers.
    Peterson AB; Wang C; Wong KK; Frey KA; Muzik O; Schipper MJ; Dewaraja YK
    Clin Nucl Med; 2023 May; 48(5):393-399. PubMed ID: 37010563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study.
    Chicheportiche A; Sason M; Godefroy J; Krausz Y; Zidan M; Oleinikov K; Meirovitz A; Gross DJ; Grozinsky-Glasberg S; Ben-Haim S
    EJNMMI Phys; 2021 Aug; 8(1):63. PubMed ID: 34436698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS - IMPROVEMENTS IN THE PROTOCOL FOR MEASUREMENT OF PATIENT RADIATION EXPOSURE].
    Chicheportiche A; Godefroy J; Krausz Y; Grozinsky-Glasberg S; Oleinikov K; Gross D; Meirovitz A; Ben-Haim S
    Harefuah; 2021 Jul; 160(7):419-424. PubMed ID: 34263567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
    Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
    [No Abstract]   [Full Text] [Related]  

  • 20. Salvage peptide receptor radionuclide therapy with [
    van der Zwan WA; Brabander T; Kam BLR; Teunissen JJM; Feelders RA; Hofland J; Krenning EP; de Herder WW
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):704-717. PubMed ID: 30267116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.